Related Experiment Video
Updated: Jun 30, 2026

Fluorescence-microscopy Screening and Next-generation Sequencing: Useful Tools for the Identification of Genes Involved in Organelle Integrity
Published on: April 13, 2012
Next Steps: Studying Diabetic Foot Infections with Next-Generation Molecular Assays
Caitlin Sande1, Zoë J Boston2, Lindsay R Kalan1
1Department of Biochemistry and Biomedical Sciences, Health Sciences Centre, McMaster University, Room 4H41, 1200 Main St West, Hamilton, ON L8N 3Z5, Canada.
Purpose Of Review:
In 2019, the International Working Group on the Diabetic Foot voiced six concerns regarding the use of molecular microbiology techniques for routine diagnosis of infection complicating diabetic foot ulcers. The purpose of this review is to evaluate contemporary evidence addressing each of these concerns and describe promising avenues for continued development of molecular microbiology assays.
Recent Findings:
Since 2019, the feasibility of conducting metagenomic and metatranscriptomic studies on diabetic foot ulcer samples has been shown. However, these preliminary studies used small samples with concerns for selection bias. We await larger-scale, longitudinal studies, potentially using the recently formed Diabetic Foot Consortium, to identify microbiome profiles associated with infection and patient outcomes. How these results would translate into a clinical diagnostic requires further clarification.
Summary:
High-throughput molecular microbiology techniques are not yet ready for clinical adoption as first-line diagnostics. However, moving from amplicon sequencing to metagenomic and metatranscriptomic studies has the potential to significantly accelerate development of assays that might meaningfully impact patient care.
Insights
Molecular microbiology shows promise for diagnosing diabetic foot infections. While not yet clinically ready, advanced techniques like metagenomics could improve patient care by identifying infection-related microbiome profiles.
Area of Science:
- Medical Microbiology
- Genomics
- Diabetic Foot Care
Background:
- Concerns exist regarding molecular microbiology for diagnosing diabetic foot infections.
- International Working Group on the Diabetic Foot highlighted key issues in 2019.
Purpose of the Study:
- Evaluate current evidence on molecular microbiology for diabetic foot ulcers.
- Address concerns raised by the International Working Group on the Diabetic Foot.
- Explore future directions for molecular diagnostic assay development.
Main Methods:
- Review of contemporary evidence on molecular microbiology techniques.
- Analysis of feasibility studies for metagenomic and metatranscriptomic analysis.
- Assessment of potential for clinical translation of advanced sequencing methods.
Main Results:
- Metagenomic and metatranscriptomic studies on diabetic foot ulcer samples are feasible.
- Preliminary studies have limitations including small sample sizes and potential bias.
- Larger, longitudinal studies are needed to link microbiome profiles to infection and outcomes.
Conclusions:
- High-throughput molecular microbiology is not yet suitable for routine clinical diagnostics.
- Advancements from amplicon sequencing to metagenomics and metatranscriptomics can accelerate assay development.
- Future molecular assays hold potential to significantly improve patient care for diabetic foot infections.
Related Concept Videos
Modern Molecular Taxonomy
Applications of Molecular Taxonomy
Rapid Identification of Pathogens
Automated Microbial Diagnostics
Diabetic Foot Ulcer

